Torley Helen's Form 4 filing
Halozyme Therapeutics, Inc. (HALO) · filed Aug 19, 2026
- Accession no.
- 0001159036-26-000108
- Filed
- Aug 19, 2026, 8:01 PM ET
- Trade date
- Aug 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 3 derivative transactions. Open-market sales total $6.28M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Torley HelenCIK 0001528185 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | MOption exerciseAcquired | +20,000 | $18.41 | +$368,200 | 787,780 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −900 | $98.96F2 | −$89,062.2 | 786,880 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −500 | $100.46F3 | −$50,228.5 | 786,380 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −2,100 | $101.77F4 | −$213,708.6 | 784,280 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −9,000 | $102.55F5 | −$922,977 | 775,280 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −7,500 | $103.48F6 | −$776,115 | 767,780 | Direct | |
| Aug 18, 2026 | Common Stock | MOption exerciseAcquired | +20,000 | $18.41 | +$368,200 | 787,780 | Direct | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −5,703 | $103.08F7 | −$587,882.35 | 782,077 | Direct | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −4,897 | $104.11F8 | −$509,826.67 | 777,180 | Direct | |
| Aug 18, 2026 | Common Stock | SSaleDisposed | −9,400 | $104.87F9 | −$985,815.6 | 767,780 | Direct | |
| Aug 19, 2026 | Common Stock | MOption exerciseAcquired | +20,000 | $18.41 | +$368,200 | 787,780 | Direct | |
| Aug 19, 2026 | Common Stock | SSaleDisposed | −7,200 | $106.36F10 | −$765,777.6 | 780,580 | Direct | |
| Aug 19, 2026 | Common Stock | SSaleDisposed | −9,600 | $107.22F11 | −$1,029,350.4 | 770,980 | Direct | |
| Aug 19, 2026 | Common Stock | SSaleDisposed | −3,200 | $107.77F12 | −$344,848 | 767,780 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | MOption exerciseDisposed | −20,000 | $18.41 | −$368,200 | 181,552 | Direct | |
| Aug 18, 2026 | Common Stock | MOption exerciseDisposed | −20,000 | $18.41 | −$368,200 | 161,552 | Direct | |
| Aug 19, 2026 | Common Stock | MOption exerciseDisposed | −20,000 | $18.41 | −$368,200 | 141,552 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average sales price per share. The shares were sold at prices ranging from $98.580 to $99.210. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
Represents a weighted average sales price per share. The shares were sold at prices ranging from $99.980 to $100.780. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F4
Represents a weighted average sales price per share. The shares were sold at prices ranging from $101.140 to $102.120. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F5
Represents a weighted average sales price per share. The shares were sold at prices ranging from $102.140 to $103.050. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F6
Represents a weighted average sales price per share. The shares were sold at prices ranging from $103.160 to $104.010. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F7
Represents a weighted average sales price per share. The shares were sold at prices ranging from $102.550 to $103.540. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F8
Represents a weighted average sales price per share. The shares were sold at prices ranging from $103.570 to $104.550. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F9
Represents a weighted average sales price per share. The shares were sold at prices ranging from $104.585 to $105.080 The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F10
Represents a weighted average sales price per share. The shares were sold at prices ranging from $105.69 to $106.680 The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F11
Represents a weighted average sales price per share. The shares were sold at prices ranging from $106.69 to $107.680 The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F12
Represents a weighted average sales price per share. The shares were sold at prices ranging from $107.69 to $107.900 The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.